Ovary

Metastases to ovary

Metastases to ovary


Author: Lucy Ma, M.D.
Editorial Board Member: Ricardo R. Lastra, M.D.
Deputy Editor-in-Chief: Gulisa Turashvili, M.D., Ph.D.
Lucy Ma, M.D.

Last author update: 8 August 2023
Last staff update: 8 August 2023

Copyright: 2002-2024, PathologyOutlines.com, Inc.

PubMed Search: Metastases ovary

Lucy Ma, M.D.
Cite this page: Ma L. Metastases to ovary. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/ovarytumormetastatic.html. Accessed December 22nd, 2024.
Definition / general
  • Secondary involvement of ovary from malignant neoplasms of extraovarian primary sites
Essential features
  • Ovary is the most common site of metastasis within the gynecologic tract
  • Colorectal and breast carcinoma are the most common primary tumors to metastasize to the ovary
  • Usually bilateral, small (< 10 cm), multinodular tumors with extraovarian spread
Terminology
ICD coding
  • ICD-10:
    • C79.60 - secondary malignant neoplasm of unspecified ovary
    • C79.61 - secondary malignant neoplasm of right ovary
    • C79.62 - secondary malignant neoplasm of left ovary
  • ICD-11:
    • 2E05.0 - malignant neoplasm metastasis in ovary
Epidemiology
Sites
  • Ovary and primary organ site, with or without other organs
Pathophysiology
  • Tumors can spread to the ovary by several pathways, depending on the primary
    • Direct extension
    • Lymphovascular / hematogeneous spread (Obstet Gynecol Int 2011;2011:612817)
    • Transcoelomic / transperitoneal dissemination (e.g., Krukenberg tumors of gastric primary)
    • Tumor cell exfoliation / transtubal spread (e.g., concurrent low grade endometrioid endometrial and ovarian carcinomas [FIGO stage IIIA endometrial carcinoma] simulating independent primary tumors) (Histopathology 2020;76:37)
Etiology
  • Malignant tumor of extraovarian primary site
Clinical features
  • Clinical features often relate to the primary tumor
  • Pelvic (ovarian) mass may be the first manifestation of the disease from a clinically occult primary (Virchows Arch 2017;470:69)
Diagnosis
  • Comprehensive medical history, physical evaluation, intraoperative evaluation, imaging, endoscopy
  • Final diagnosis is rendered by histopathology and immunohistochemistry (with or without molecular studies)
Laboratory
  • CA-125 is not a useful biomarker in the primary diagnostics of metastases to the ovary (Clin Exp Metastasis 2017;34:295)
  • CA-125/CEA ratio may be of clinical use in distinguishing primary ovarian tumors from colorectal carcinoma metastases (Tumour Biol 1992;13:18)
Radiology description
  • No specific imaging features differentiate primary ovarian malignancy from metastatic ovarian tumors (Magn Reson Imaging Clin N Am 2023;31:93)
  • MRI appearances that suggest a mucinous lesion should trigger a search on the scan for an alternative primary mass in the gastrointestinal tract
Radiology images

Images hosted on other servers:
Missing Image Missing Image

Solid and cystic bilateral ovarian masses

Prognostic factors
  • Ovarian metastases from colorectal carcinoma are often unresponsive to chemotherapy and are associated with poor survival (Cancer 2017;123:1134)
Case reports
Treatment
  • Debulking surgery with or without chemotherapy
Gross description
  • Bilateral ovarian involvement (overall occurs in 40 - 80% of cases)
    • Primary mucinous ovarian tumors, uncommonly bilateral
  • Size: usually < 10 cm
    • Generally applied to metastatic mucinous tumors, though may be less reliable than previously reported (Gynecol Oncol 2006;101:152)
  • Multinodular, solid and cystic, or friable
  • Surface involvement
  • Hilar involvement (common in hematogenous spread)
Gross images

Images hosted on other servers:
Bilateral ovarian masses with multinodular cut surfaces

Bilateral ovarian masses with multinodular cut surfaces

Microscopic (histologic) description
  • Morphology varies with appearance of primary tumor
  • General features
  • Colorectal adenocarcinoma
    • Dilated glands with cribriform epithelium draped along the periphery of luminal dirty necrosis (garland pattern)
  • Low grade appendiceal mucinous neoplasm
    • Hypermucinous columnar epithelium with low grade cytologic atypia
    • Retraction of epithelium from underlying stroma is commonly seen
    • Abundant pseudomyxoma ovarii
  • Gastric carcinoma
    • Frequently presents as Krukenberg tumor (composed predominantly of signet ring cells)
    • Stroma may alternate from hypercellular to hypocellular (edematous)
  • Breast carcinoma
    • Lobular or ductal differentiation
    • Signet ring cells may be present
  • Endocervical adenocarcinoma
    • HPV associated
      • Variety of glandular patterns
      • Epithelium with hyperchromatic nuclei, apical mitoses, basal apoptoses
    • HPV independent, gastric type
      • Mucinous epithelium with clear / pale cytoplasm with distinct borders
      • Cytologic atypia may range from minimal to severe
  • Endometrial adenocarcinoma
  • Melanoma
    • Follicle-like spaces are frequently seen
    • Diffuse or nodular growth is common
    • Intracytoplasmic melanin pigment
Microscopic (histologic) images

Contributed by Lucy Ma, M.D.
Krukenberg tumor Krukenberg tumor

Krukenberg tumor

Metastatic cervical adenosquamous carcinoma Metastatic cervical adenosquamous carcinoma

Metastatic cervical adenosquamous carcinoma


Metastatic low grade appendiceal mucinous neoplasm

Metastatic low
grade appendiceal
mucinous
neoplasm

Metastatic lobular breast carcinoma Metastatic lobular breast carcinoma

Metastatic lobular breast carcinoma

Virtual slides

Images hosted on other servers:
Metastatic breast carcinoma to ovary

Metastatic breast carcinoma to the ovary

Metastatic malignant melanoma to the ovary

Metastatic malignant melanoma to the ovary

Metastatic pancreatic adenocarcinoma to the ovary

Metastatic pancreatic adenocarcinoma to the ovary

Metastatic hepatocellular carcinoma to the ovary

Metastatic hepatocellular carcinoma to the ovary

Positive stains
Negative stains
Molecular / cytogenetics description
  • KRAS, SMAD4 and NTKR1 mutations are more frequent in cases of ovarian metastasis from colorectal carcinoma than in cases of colorectal carcinoma without ovarian metastasis (Cancer 2017;123:1134)
Sample pathology report
  • Fallopian tube and ovary, right and left, bilateral salpingo-oophorectomy:
    • Metastatic carcinoma, consistent with patient's known history of breast primary, involving bilateral ovaries (see comment)
    • Bilateral fallopian tubes, negative for tumor
    • Comment: On immunohistochemistry, the tumor cells are positive for GATA3, mammaglobin and GCDFP-15, while negative for PAX8. These findings support the diagnosis above.
Differential diagnosis
Board review style question #1

A 65 year old woman with an ovarian mass undergoes an oophorectomy. A representative section of the mass is shown above. Which of the following immunoprofiles best supports a diagnosis of metastatic colorectal adenocarcinoma?

  1. CK7+, CK20+, PAX8-, GATA3+, CDX2-, SATB2-
  2. CK7+, CK20-, PAX8+, GATA3-, CDX2+, SATB2-
  3. CK7-, CK20+, PAX8-, GATA3-, CDX2+, SATB2+
  4. CK7-, CK20-, PAX8-, GATA3-, CDX2-, SATB2-
Board review style answer #1
C. CK7-, CK20+, PAX8-, GATA3-, CDX2+, SATB2+. Compared with the other answer choices, this immunoprofile best supports a colorectal adenocarcinoma primary, which is typically CK7-, CK20+, PAX8-, GATA3-, CDX2+ and SATB2+. Answer A is incorrect as it fits the immunoprofile for a metastatic urothelial carcinoma. Answer B is incorrect as it is more consistent with a primary ovarian endometrioid carcinoma. Answer D is incorrect as it is not immunoreactive to any typical adenocarcinoma markers.

Comment Here

Reference: Metastases to ovary
Board review style question #2
Which of the following organs is the most common site of metastasis within the gynecologic tract?

  1. Cervix
  2. Endometrium
  3. Fallopian tube
  4. Ovary
  5. Vulva
Board review style answer #2
D. Ovary. The ovary is the most common site of metastasis within the gynecologic tract. Answers A, B, C and E are incorrect because the vagina is the second most frequent site of metastasis within the gynecologic tract following the ovary (Cancer 1984;53:1978).

Comment Here

Reference: Metastases to ovary
Back to top
Image 01 Image 02